Meet Dr. Posey
In Person Walks
Give 5X the Hope
this Mother’s Day
Career Development Awards Announced
International Pancreatic Cancer Trial opens
Researchers testing organoids use in predicting treatment outcomesA new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients based on the molecular traits of tumors. The Pancreatic Cancer Convergence Dream Team is funded by the Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer® (SU2C), SU2C Canada and Pancreatic Cancer Canada. The team will be led by Jennifer Knox, MD, the Lewitt Chair in Pancreatic Cancer Research at the Princess Margaret Cancer Centre, part of University Health Network, and professor of medicine at the University of Toronto in Canada, and Elizabeth Jaffee, MD, a professor of oncology and deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland.
Remembering Stephen Grand
Stephen Grand: Pancreatic Cancer Fighter and Research FunderOur hearts are broken at the news of the passing of Lustgarten ally and donor, Stephen Grand of Belvedere, CA. A passionate and insightful philanthropist, as well as a pancreatic cancer patient, Steve was in the unique position of understanding the urgency of moving the research along quickly and the need to invest in the most innovative science with the greatest opportunity to drive real progress. Tomorrow is promised to no one, but Steve’s hope was that through his philanthropy pancreatic patients like himself would someday be promised more time.
Register For Lustgarten Live!
Donor Helps Bring Science to Clinic
Meet Our New CEO
The Lustgarten Foundation today announced the appointment of Linda Tantawi as Chief Executive Officer. As CEO, Tantawi will expand the organization’s national presence to achieve its mission of finding a cure for pancreatic cancer. Since 1998, the Lustgarten Foundation has been at the forefront of advancements in understanding the disease and developing new and more effective treatments.
Announcing Tantawi’s appointment, Foundation Chairman Andrew Lustgarten said: “With the incredible vision of the Foundation’s previous leaders, we’ve made important strides—taking pancreatic cancer from an unsupported ‘orphan disease,’ to one that is now supported by a robust research program. Linda’s leadership skills and extensive experience in fundraising for national cancer nonprofits will help take the Foundation, and the research we support, to the next level.”